| |
[摘要]：P450 enzymes comprising the human CYP4F gene Subfamily are catalysts of eicosanoid (e.g., 20-HETE and leukotriene B4) formation and degradation, although the role that individual CYP4F proteins play in these metabolic processes is not well defined. Thus, we developed antibodies to assess the tissue-specific expression and function of CYP4F2, one of four CYP4F P450s found in human liver and kidney. Peptide antibodies elicited in rabbits to CYP4F2 amino acid residues 61-74 (WGHQGMVNFTEEG) and 65-77 (GMVNPTEEGMRVL) recognized oil immunoblots only CYP4F2 and not CYP4F3b, CYP4F11 I I or CYP4F12. immunoquantitation with anti-CYP4F2 peptide IgG showed highly variable CYP4F2 expression in liver (16.4 +/- 18.6 pmol/mg microsomal protein; n = 29) and kidney cortex (3.9 +/- 3.8 pmol/mg: n = 10), with two Subjects lacking the hepatic or renal enzyme entirely. CYP4F2 content in liver microsomes was significantly Correlated (r >= 0.63: p < 0.05) with leukotriene B4 and arachiclonate omega-hydroxylase activities, which are both CYP4F2-catalyzed. Our study provides the first example of a peptide antibody that recognizes a single CYP4F P450 expressed in human liver and kidney, namely CYP4F2. Immunoquantitation and correlation analyses performed with this antibody suggest that CYP4F2 functions as a predominant LTB4 and arachiclonate omega-hydroxylase in human liver. (c) 2008 Elsevier Inc. All rights reserved. |
|
